98%
921
2 minutes
20
The noradrenergic neurons of the locus coeruleus (LC) are associated with various brain functions and psychiatric disorders, such as addiction and depression. It has been shown that neuropeptide galanin (GAL) inhibits neuronal excitability in LC, but the mechanisms remain unclear. In the present study, we investigated the ionic and signal transduction mechanisms underlying inhibitory effect of GAL on LC neurons using whole-cell patch clamp recording in rat brain slices. Bath application of GAL decreased the spontaneous firings and induced a dose-dependent hyperpolarization of LC neurons and this effect was attenuated by knockdown of Galr1, but not Galr2, confirming that mainly GALR1 mediates the inhibition effect of GAL. The inhibitory effect of GAL was also blocked by treatments of pertussis toxin (PTX), GTP-γ-s or GDP-β-s, respectively, indicating that the functions of PTX sensitive G protein are required for GAL-induced hyperpolarization. Moreover, the blockers of GIRK (tertiapin-Q or SCH2 3390 hydrochloride) attenuated the GAL response while blocker of BK/SK/K channels or TASK-1/3 channels did not affect it significantly, suggesting that GIRK channels play an important role in GAL-induced hyperpolarization in LC neurons. Taken together, the inhibitory effect of GAL on LC neurons is mediated by GALR1 via PTX-sensitive G proteins, which activate GIRK channels.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.bbrc.2018.05.181 | DOI Listing |
Mol Psychiatry
September 2025
Institute of Physiology and Pathophysiology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Adolescent binge drinking is a risk behavior associated with the development of neuropsychiatric disorders later in life, but the pathophysiological mechanisms rendering the adolescent brain vulnerable to the long-term consequences of heavy alcohol consumption are only partially understood. Here, we used a mouse model of adolescent binge drinking and focussed on G protein-gated inwardly rectifying potassium (GIRK) channels which are a molecular target of both ethanol and the pluripotent growth and differentiation factor activin A. In whole-cell recordings from dentate gyrus granule cells in brain slices from alcohol-naive mice, we found a striking reversal of the effect of activin A on ethanol-evoked GIRK current as the mice matured: Whereas activin A reduced the ethanol response in cells from adult mice, the already lower ethanol threshold in cells from young mice was brought down even further by activin A.
View Article and Find Full Text PDFInt J Biol Macromol
August 2025
Drug Discovery and Development Laboratory (DDD Lab), Department of Pharmaceutical Technology, Jadavpur University, Kolkata 700032, India. Electronic address:
GIRK channels are crucial in regulating cardiac excitability and present promising therapeutic targets. Notably, the genetic absence of GIRK4 prevents atrial fibrillation (AF) in knockout mice, yet research on specific GIRK4 modulators is limited. Addressing the challenges posed by GIRK4's intrinsic constitutive activity, we hypothesize that a GIRK inverse agonist unlike the traditional antagonist can actively downregulate the channel activity alongside reduction of the aberrant basal signaling which can translate to enhanced therapeutic efficacy.
View Article and Find Full Text PDFJ Neurosci
September 2025
Department of Neuroscience, Karolinska Institutet, Solna 171 77, Sweden.
GABA receptors (GABARs) are an important building block in neural activity. Despite their widely hypothesized role in many basic neuronal functions and mental disorder symptomatology, there is a lack of biophysically and biochemically detailed models of these receptors and the way they mediate neuronal inhibition. Here, we developed a computational model for the activation of GABARs and its effects on the activation of G protein-coupled inwardly rectifying potassium (GIRK) channels as well as inhibition of voltage-gated Ca channels.
View Article and Find Full Text PDFBiology (Basel)
May 2025
Laboratory of Physiology-Neurophysiology, Department of Medicine, University of Patras, 26504 Patras, Greece.
Endocannabinoids, acting primarily through CB1 receptors, are critical modulators of neuronal activity, influencing cognitive functions and emotional processing. CB1 receptors are highly expressed in the hippocampus, primarily on GABAergic interneurons, modulating the excitation/inhibition balance. Previous evidence suggests the functional heterogeneity of CB1 receptors along the dorsoventral axis of the hippocampus.
View Article and Find Full Text PDFACS Chem Neurosci
July 2025
Department of Medical and Translational Biology, Wallenberg Centre for Molecular Medicine, Umeå University, 901 87 Umeå, Sweden.
The dopamine D receptor (DR) is prominently expressed in the striatum and cerebral cortex and is an attractive target for treating Parkinson's disease and cognitive impairment in schizophrenia. While newer, noncatechol DR agonists such as tavapadon have shown promise in recent clinical trials, the therapeutic utility of earlier catechol agonists such as A77636 was hampered by tolerance development. The mechanism underlying tolerance induction was suggested to involve very slow A77636 dissociation from the DR, promoting prominent arrestin recruitment and receptor internalization associated with delayed recycling to the cell surface.
View Article and Find Full Text PDF